Study to Evaluate Plasmin for the Creation of a Posterior Vitreous Detachment

Stopped early · Phase 2

Conditions studied: Vitreoretinal Traction Syndrome

In brief

Plasmin is expected to create a posterior vitreous detachment. The pharmacological creation of a posterior vitreous detachment may be beneficial in a variety of conditions.

Key facts

Study ID

NCT00348439

Run by

Bausch & Lomb Incorporated

People needed

29

Starts

2006-04-01

Expected to finish

2007-08-01

Last updated by the study team

2019-06-21

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients who would benefit from a posterior vitreous detachment, as determined by the evaluating ophthalmologist.

You may not qualify if…

• Presence of a posterior vitreous detachment in the study eye
• History of vitrectomy in the study eye
• Proliferative diabetic retinopathy in the study eye
• Presence of media opacity that precludes quality examination of the vitreous and fundus.

Where it is running

• Emory University — Atlanta, Georgia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.